Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $777.46 ($79K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Seasonal sale ($79k) by Director — this insider has traded REGN in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $777.46 | 7 | $5K | 6.9% |
| 2 | $778.30 | 2 | $2K | 2.0% |
| 3 | $779.69 | 5 | $4K | 5.0% |
| 4 | $780.69 | 3 | $2K | 3.0% |
| 5 | $781.21 | 2 | $2K | 2.0% |
| 6 | $782.62 | 2 |
| $2K |
| 2.0% |
| 7 | $783.62 | 10 | $8K | 10.0% |
| 8 | $784.48 | 9 | $7K | 9.0% |
| 9 | $785.48 | 11 | $9K | 11.0% |
| 10 | $786.61 | 7 | $6K | 7.0% |
| 11 | $787.34 | 2 | $2K | 2.0% |
| 12 | $788.96 | 20 | $16K | 20.1% |
| 13 | $789.28 | 20 | $16K | 20.1% |
| Total | $785.50 avg | 100 | $79K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |
| REGN | SELL | 2024-10-03 | $105K | — | Filing → |